Skip to content
Application 210605
- Type
- BLA
- Sponsor
- MYLAN PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SEMGLEE | INSULIN GLARGINE | INJECTABLE;INJECTION | 100 UNITS/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 49502-195 | SEMGLEE | insulin glargine | Mylan Specialty L.P. | BLA | Current |
| 49502-195 | SEMGLEE | insulin glargine | Mylan Specialty L.P. | BLA | Current |
| 49502-195 | SEMGLEE | insulin glargine | Mylan Specialty L.P. | BLA | Current |
| 49502-195 | SEMGLEE | insulin glargine | Mylan Specialty L.P. | BLA | Current |
| 49502-196 | SEMGLEE | insulin glargine | Mylan Specialty L.P. | BLA | Current |
| 49502-196 | SEMGLEE | insulin glargine | Mylan Specialty L.P. | BLA | Current |
| 49502-196 | SEMGLEE | insulin glargine | Mylan Specialty L.P. | BLA | Current |
| 49502-196 | SEMGLEE | insulin glargine | Mylan Specialty L.P. | BLA | Current |
| 50090-5835 | SEMGLEE | insulin glargine | A-S Medication Solutions | BLA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 65661 | ORIG | 2020-12-21 |
| 63490 | ORIG | 2020-06-12 |
| 63485 | APPL | 2020-06-11 |
| 63484 | ORIG | 2020-06-11 |